ChemoCentryx to Hold Fourth Quarter 2015 Financial Results Conference Call on Monday, March 14, 2016
MOUNTAIN VIEW, Calif., Feb. 29, 2016 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq:CCXI), a clinical-stage biopharmaceutical company developing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer, today …